The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $4.63, representing a -3.14% change from its previous ...
Recursion Pharmaceuticals Inc. stocks have been trading down by -4.08 percent after cautious reaction to its latest AI ...
Biyoloji ve tıpta devrim yaratan pek çok keşif, bilim insanlarının doğada bulunan moleküler makinelerin şaşırtıcı çeşitliliği ...
工业3D打印龙头，港股IPO突遇监管问询！10月6日消息，证监会要求联泰科技就境外发行上市补充材料，公司今年6月正式递表港交所，海通国际独家保荐。按2025年出货量计算，公司位居国内工业级3D打印设备厂商第一；按收入计，位列全球工业级3D打印综合方案商第四，以AI赋能技术，布局人形机器人丶鞋业两大增量赛道。财务层面营收稳步增长，2025年营收5.63亿元，但利润波动较大，连续三年账面亏损，经调整後 ...
每5台智能电视就有一颗它的芯片，晶晨股份港股上市再提速！9月30日证监会披露，晶晨股份境外发行上市正式获备案，拟发行不超5381.55万股H股。公司此前已两次递表港交所，2019年登陆科创板，当前总市值超400亿元。作为全球第四大智能终端SoC厂商， ...
If you're looking to build a powerful Blink deck for your next MTG Commander project, then these are the best Commanders to ...
ARK Invest sold $17.1M in Twist Bioscience shares and purchased Recursion Pharmaceuticals, Intellia Therapeutics, and ...
Cathie Wood’s ARK Invest continued to reshuffle its healthcare portfolio Monday across its ETFs, selling heavily in Twist ...
Tempus AI slides 7.63% today to $77.22 as selling pressure emerges despite bullish momentum and FDA clearance news.
ARK Invest sold Twist Bioscience shares and bought Recursion Pharmaceuticals, Intellia Therapeutics, and Veracyte stock on ...
Pune, India, October 6th, 2026, FinanceWireThis is a paid advertisement.Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) ...
Across the ARK Genomic Revolution ETF and the ARK Innovation ETF, Wood bought $6.1 million in Recursion Pharmaceuticals, $1.2 million in Intellia Therapeutics, and $5.3 million in Veracyte.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results